Your browser doesn't support javascript.
loading
Loss of function mutations in GEMIN5 cause a neurodevelopmental disorder.
Kour, Sukhleen; Rajan, Deepa S; Fortuna, Tyler R; Anderson, Eric N; Ward, Caroline; Lee, Youngha; Lee, Sangmoon; Shin, Yong Beom; Chae, Jong-Hee; Choi, Murim; Siquier, Karine; Cantagrel, Vincent; Amiel, Jeanne; Stolerman, Elliot S; Barnett, Sarah S; Cousin, Margot A; Castro, Diana; McDonald, Kimberly; Kirmse, Brian; Nemeth, Andrea H; Rajasundaram, Dhivyaa; Innes, A Micheil; Lynch, Danielle; Frosk, Patrick; Collins, Abigail; Gibbons, Melissa; Yang, Michele; Desguerre, Isabelle; Boddaert, Nathalie; Gitiaux, Cyril; Rydning, Siri Lynne; Selmer, Kaja K; Urreizti, Roser; Garcia-Oguiza, Alberto; Osorio, Andrés Nascimento; Verdura, Edgard; Pujol, Aurora; McCurry, Hannah R; Landers, John E; Agnihotri, Sameer; Andriescu, E Corina; Moody, Shade B; Phornphutkul, Chanika; Sacoto, Maria J Guillen; Begtrup, Amber; Houlden, Henry; Kirschner, Janbernd; Schorling, David; Rudnik-Schöneborn, Sabine; Strom, Tim M.
Afiliação
  • Kour S; Department of Pediatrics, Childrens Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Rajan DS; Department of Pediatrics, Childrens Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Fortuna TR; Department of Pediatrics, Childrens Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Anderson EN; Department of Pediatrics, Childrens Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Ward C; Department of Pediatrics, Childrens Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Lee Y; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lee S; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Shin YB; Department of Rehabilitative Medicine, Pusan National University School of Medicine, Pusan, Republic of Korea.
  • Chae JH; Department of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Choi M; Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Siquier K; Department of Pediatrics, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Cantagrel V; Developmental Brain Disorders Laboratory, Paris University, Imagine Institute, INSERM UMR, Paris, France.
  • Amiel J; Developmental Brain Disorders Laboratory, Paris University, Imagine Institute, INSERM UMR, Paris, France.
  • Stolerman ES; Department of Genetics, AP-HP, Necker Enfants Malades Hospital, Paris University, Imagine Institute, Paris, France.
  • Barnett SS; Greenwood Genetic Center, Greenwood, SC, USA.
  • Cousin MA; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Castro D; Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA.
  • McDonald K; Department of Pediatrics and Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Kirmse B; University of Mississippi Medical Center, Jackson, MS, USA.
  • Nemeth AH; Division of Genetics, University of Mississippi Medical Center, Jackson, MS, USA.
  • Rajasundaram D; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Innes AM; Oxford Centre for Genomic Medicine, Oxford University Hospitals National Health Service Foundation Trust, Oxford, UK.
  • Lynch D; Department of Pediatrics, Division of Health Informatics, Childrens Hospital of Pittsburgh, Pittsburgh, PA, USA.
  • Frosk P; Department of Medical Genetics and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Collins A; Department of Medical Genetics and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Canada.
  • Gibbons M; Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.
  • Yang M; Department of Pediatrics and Neurology, Children's Hospital of Colorado, University of Colorado School of Medicine, Aurora, CO, USA.
  • Desguerre I; Department of Pediatrics and Neurology, Children's Hospital of Colorado, University of Colorado School of Medicine, Aurora, CO, USA.
  • Boddaert N; Department of Pediatrics and Neurology, Children's Hospital of Colorado, University of Colorado School of Medicine, Aurora, CO, USA.
  • Gitiaux C; Department of Pediatric Neurology, AP-HP, Necker Enfants Malades Hospital, Paris University Imagine Institute, Paris, France.
  • Rydning SL; Department of Pediatric Radiology, AP-HP, Necker Enfants Malades Hospital, Paris University Imagine Institute, Paris, France.
  • Selmer KK; Department of Pediatric Neurophysiology AP-HP, Necker Enfants Malades Hospital, Paris University, Paris, France.
  • Urreizti R; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Garcia-Oguiza A; Department of Research and Development, Division of Neuroscience, Oslo University Hospital and the University of Oslo, Oslo, Norway.
  • Osorio AN; Department of Clinical Biochemistry, Institut de Recerca Sant Joan de Déu and CIBERER, Barcelona, Spain.
  • Verdura E; Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Pujol A; Hospital Sant Joan de Déu, Barcelona, Spain.
  • McCurry HR; Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Landers JE; Centre for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
  • Agnihotri S; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
  • Andriescu EC; Center for Mendelian Genomics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Moody SB; Department of Neurology, University of Massachusetts Medical School, Worcester, MA, USA.
  • Phornphutkul C; Department of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Sacoto MJG; Department of Pediatrics, University of Texas Health Science Center, Houston, TX, USA.
  • Begtrup A; Department of Pediatrics, University of Texas Health Science Center, Houston, TX, USA.
  • Houlden H; Department of Pediatrics, Division of Human Genetics, Rhode Island Hospital and Warren Alpert Medical School of Brown University, Providence, RI, USA.
  • Kirschner J; GeneDx, Gaithersburg, MD, USA.
  • Schorling D; GeneDx, Gaithersburg, MD, USA.
  • Rudnik-Schöneborn S; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK.
  • Strom TM; Department of Neuropediatrics and Muscle Disorders, Medical Center,, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Nat Commun ; 12(1): 2558, 2021 05 07.
Article em En | MEDLINE | ID: mdl-33963192
ABSTRACT
GEMIN5, an RNA-binding protein is essential for assembly of the survival motor neuron (SMN) protein complex and facilitates the formation of small nuclear ribonucleoproteins (snRNPs), the building blocks of spliceosomes. Here, we have identified 30 affected individuals from 22 unrelated families presenting with developmental delay, hypotonia, and cerebellar ataxia harboring biallelic variants in the GEMIN5 gene. Mutations in GEMIN5 perturb the subcellular distribution, stability, and expression of GEMIN5 protein and its interacting partners in patient iPSC-derived neurons, suggesting a potential loss-of-function mechanism. GEMIN5 mutations result in disruption of snRNP complex assembly formation in patient iPSC neurons. Furthermore, knock down of rigor mortis, the fly homolog of human GEMIN5, leads to developmental defects, motor dysfunction, and a reduced lifespan. Interestingly, we observed that GEMIN5 variants disrupt a distinct set of transcripts and pathways as compared to SMA patient neurons, suggesting different molecular pathomechanisms. These findings collectively provide evidence that pathogenic variants in GEMIN5 perturb physiological functions and result in a neurodevelopmental delay and ataxia syndrome.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribonucleoproteínas Nucleares Pequenas / Regulação da Expressão Gênica no Desenvolvimento / Proteínas do Complexo SMN / Células-Tronco Pluripotentes Induzidas / Transtornos do Neurodesenvolvimento / Neurônios Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribonucleoproteínas Nucleares Pequenas / Regulação da Expressão Gênica no Desenvolvimento / Proteínas do Complexo SMN / Células-Tronco Pluripotentes Induzidas / Transtornos do Neurodesenvolvimento / Neurônios Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos